Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope

This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021, Vol.9 (2), p.873-877
Main Authors: Kathrotiya, Manthan, Radhakrishnan, Vivek S, Bhave, Saurabh J, Kumar, Jeevan, Roychowdhury, Mita, Arun, Indu, Das, Jayanta, Chandy, Mammen, Nair, Reena
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3673